These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11433707)

  • 1. [Nerve growth factor (NGF) in treatment of diabetic polyneuropathy. One hope less?].
    Quasthoff S; Hartung HP
    Nervenarzt; 2001 Jun; 72(6):456-9. PubMed ID: 11433707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group.
    Apfel SC; Schwartz S; Adornato BT; Freeman R; Biton V; Rendell M; Vinik A; Giuliani M; Stevens JC; Barbano R; Dyck PJ
    JAMA; 2000 Nov; 284(17):2215-21. PubMed ID: 11056593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis.
    Bonini S; Lambiase A; Rama P; Sinigaglia F; Allegretti M; Chao W; Mantelli F;
    Ophthalmology; 2018 Sep; 125(9):1332-1343. PubMed ID: 29653858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291.
    McArthur JC; Yiannoutsos C; Simpson DM; Adornato BT; Singer EJ; Hollander H; Marra C; Rubin M; Cohen BA; Tucker T; Navia BA; Schifitto G; Katzenstein D; Rask C; Zaborski L; Smith ME; Shriver S; Millar L; Clifford DB; Karalnik IJ
    Neurology; 2000 Mar; 54(5):1080-8. PubMed ID: 10720278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group.
    Apfel SC; Kessler JA; Adornato BT; Litchy WJ; Sanders C; Rask CA
    Neurology; 1998 Sep; 51(3):695-702. PubMed ID: 9748012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?
    Apfel SC
    Int Rev Neurobiol; 2002; 50():393-413. PubMed ID: 12198818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human studies of recombinant human nerve growth factor and diabetic peripheral neuropathy.
    Freeman R
    Eur Neurol; 1999; 41 Suppl 1():20-6. PubMed ID: 10023125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of ubiquinone in diabetic polyneuropathy: a randomized double-blind placebo-controlled study.
    Hernández-Ojeda J; Cardona-Muñoz EG; Román-Pintos LM; Troyo-Sanromán R; Ortiz-Lazareno PC; Cárdenas-Meza MA; Pascoe-González S; Miranda-Díaz AG
    J Diabetes Complications; 2012; 26(4):352-8. PubMed ID: 22595020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and pharmacokinetics of escalating doses of human recombinant nerve growth factor eye drops in a double-masked, randomized clinical trial.
    Ferrari MP; Mantelli F; Sacchetti M; Antonangeli MI; Cattani F; D'Anniballe G; Sinigaglia F; Ruffini PA; Lambiase A
    BioDrugs; 2014 Jun; 28(3):275-83. PubMed ID: 24327173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.
    Ziegler D; Hanefeld M; Ruhnau KJ; Hasche H; Lobisch M; Schütte K; Kerum G; Malessa R
    Diabetes Care; 1999 Aug; 22(8):1296-301. PubMed ID: 10480774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind placebo-controlled clinical trial of recombinant human brain-derived neurotrophic factor (rhBDNF) in diabetic polyneuropathy.
    Wellmer A; Misra VP; Sharief MK; Kopelman PG; Anand P
    J Peripher Nerv Syst; 2001 Dec; 6(4):204-10. PubMed ID: 11800042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group.
    Dyck PJ; Dyck PJ; Larson TS; O'Brien PC; Velosa JA
    Diabetes Care; 2000 Apr; 23(4):510-7. PubMed ID: 10857944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant Human Nerve Growth Factor Treatment Promotes Photoreceptor Survival in the Retinas of Rats with Retinitis Pigmentosa.
    Sacchetti M; Mantelli F; Rocco ML; Micera A; Brandolini L; Focareta L; Pisano C; Aloe L; Lambiase A
    Curr Eye Res; 2017 Jul; 42(7):1064-1068. PubMed ID: 28632034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial.
    Schwartz S; Etropolski M; Shapiro DY; Okamoto A; Lange R; Haeussler J; Rauschkolb C
    Curr Med Res Opin; 2011 Jan; 27(1):151-62. PubMed ID: 21162697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Pregabalin in the Treatment of Patients With Painful Diabetic Peripheral Neuropathy and Pain on Walking.
    Huffman C; Stacey BR; Tuchman M; Burbridge C; Li C; Parsons B; Pauer L; Scavone JM; Behar R; Yurkewicz L
    Clin J Pain; 2015 Nov; 31(11):946-58. PubMed ID: 25565583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical Citrullus colocynthis (bitter apple) extract oil in painful diabetic neuropathy: A double-blind randomized placebo-controlled clinical trial.
    Heydari M; Homayouni K; Hashempur MH; Shams M
    J Diabetes; 2016 Mar; 8(2):246-52. PubMed ID: 25800045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.
    Ziegler D; Reljanovic M; Mehnert H; Gries FA
    Exp Clin Endocrinol Diabetes; 1999; 107(7):421-30. PubMed ID: 10595592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human nerve growth factor and diabetic polyneuropathy.
    Zochodne DW; Said G
    Neurology; 1998 Sep; 51(3):662-3. PubMed ID: 9748004
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of dextromethorphan/quinidine at two dosage levels for diabetic neuropathic pain: a double-blind, placebo-controlled, multicenter study.
    Shaibani AI; Pope LE; Thisted R; Hepner A
    Pain Med; 2012 Feb; 13(2):243-54. PubMed ID: 22314263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered patients from two 1-year clinical trials.
    Tesfaye S; Tandan R; Bastyr EJ; Kles KA; Skljarevski V; Price KL;
    Diabetes Care; 2007 Oct; 30(10):2626-32. PubMed ID: 17623822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.